Published by Benjamin Chiou on 14th March 2024
(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.
URL: http://www.digitallook.com/dl/news/story/34154572/...